| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.008 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.009 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |